These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24828815)

  • 1. Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles.
    Ye WL; Du JB; Zhang BL; Na R; Song YF; Mei QB; Zhao MG; Zhou SY
    PLoS One; 2014; 9(5):e97358. PubMed ID: 24828815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
    Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
    Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human Breast Cancer.
    Liao TT; Han JF; Zhang FY; Na R; Ye WL
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.
    Song YF; Liu DZ; Cheng Y; Liu M; Ye WL; Zhang BL; Liu XY; Zhou SY
    Sci Rep; 2015 Nov; 5():16125. PubMed ID: 26530454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
    Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
    Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
    Wu G; Wang Z; Bian X; Du X; Wei C
    Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate.
    Yang T; Xu L; Li B; Li W; Ma X; Fan L; Lee RJ; Xu C; Xiang G
    Int J Nanomedicine; 2017; 12():2505-2515. PubMed ID: 28408821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-functional core-shell Fe
    S R; M P
    Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
    Zhang C; Zhang Z; Zhao L
    Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin.
    Huan M; Zhang B; Teng Z; Cui H; Wang J; Liu X; Xia H; Zhou S; Mei Q
    PLoS One; 2012; 7(9):e44116. PubMed ID: 23028490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy.
    Tan R; Tian D; Liu J; Wang C; Wan Y
    Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of doxorubicin α-linolenic acid conjugate and evaluation of its antitumor activity.
    Liang CH; Ye WL; Zhu CL; Na R; Cheng Y; Cui H; Liu DZ; Yang ZF; Zhou SY
    Mol Pharm; 2014 May; 11(5):1378-90. PubMed ID: 24720787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery.
    Ma K; Li W; Zhu G; Chi H; Yin Y; Li Y; Zong Y; Guo Z; Wang L; Xu W; Cui C; Zhou H; Xu J
    J Drug Target; 2021 Sep; 29(8):884-891. PubMed ID: 33571019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Zhang C; Wu Y; Dong Y; Xu H; Zhao L
    Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
    Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
    Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actively targeted delivery of doxorubicin to bone metastases by a pH-sensitive conjugation.
    Ye WL; Zhao YP; Na R; Li F; Mei QB; Zhao MG; Zhou SY
    J Pharm Sci; 2015 Jul; 104(7):2293-303. PubMed ID: 25980534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumor-targeted, intracellular activatable and theranostic nanodiamond drug platform for strongly enhanced in vivo antitumor therapy.
    Du X; Li L; Wei S; Wang S; Li Y
    J Mater Chem B; 2020 Feb; 8(8):1660-1671. PubMed ID: 32011619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.